Vanda Pharmaceuticals Inc (VNDA)
4.56
-0.07
(-1.51%)
USD |
NASDAQ |
Apr 24, 16:00
4.565
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Market Cap: 262.37M for April 24, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
April 24, 2024 | 262.37M |
April 23, 2024 | 266.40M |
April 22, 2024 | 276.18M |
April 19, 2024 | 294.02M |
April 18, 2024 | 285.96M |
April 17, 2024 | 301.50M |
April 16, 2024 | 233.03M |
April 15, 2024 | 233.60M |
April 12, 2024 | 237.05M |
April 11, 2024 | 246.26M |
April 10, 2024 | 246.26M |
April 09, 2024 | 250.86M |
April 08, 2024 | 259.49M |
April 05, 2024 | 277.33M |
April 04, 2024 | 283.08M |
April 03, 2024 | 290.56M |
April 02, 2024 | 224.97M |
April 01, 2024 | 237.05M |
March 28, 2024 | 236.48M |
March 27, 2024 | 223.82M |
March 26, 2024 | 222.09M |
March 25, 2024 | 222.67M |
March 22, 2024 | 223.82M |
March 21, 2024 | 224.97M |
March 20, 2024 | 218.64M |
Date | Value |
---|---|
March 19, 2024 | 216.34M |
March 18, 2024 | 215.77M |
March 15, 2024 | 219.22M |
March 14, 2024 | 218.64M |
March 13, 2024 | 220.94M |
March 12, 2024 | 223.25M |
March 11, 2024 | 230.44M |
March 08, 2024 | 222.67M |
March 07, 2024 | 219.79M |
March 06, 2024 | 224.97M |
March 05, 2024 | 238.21M |
March 04, 2024 | 245.69M |
March 01, 2024 | 265.25M |
February 29, 2024 | 257.19M |
February 28, 2024 | 257.19M |
February 27, 2024 | 264.10M |
February 26, 2024 | 262.37M |
February 23, 2024 | 256.04M |
February 22, 2024 | 249.14M |
February 21, 2024 | 249.71M |
February 20, 2024 | 250.29M |
February 16, 2024 | 252.01M |
February 15, 2024 | 251.44M |
February 14, 2024 | 244.53M |
February 13, 2024 | 233.60M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
194.46M
Minimum
Nov 09 2023
1.197B
Maximum
Jun 30 2021
629.92M
Average
624.21M
Median
Apr 18 2022
Market Cap Benchmarks
ADMA Biologics Inc | 1.474B |
INVO Bioscience Inc | 3.209M |
Johnson & Johnson | 357.93B |
Nektar Therapeutics | 253.39M |
Invivyd Inc | 253.94M |
Market Cap Related Metrics
PE Ratio | 87.06 |
PS Ratio | 1.362 |
Price to Book Value | 0.4815 |
Price to Free Cash Flow | 21.14 |
Price | 4.56 |
Earnings Yield | 1.15% |
Normalized PE Ratio | 87.06 |